Suppr超能文献

全身麻醉下硬膜外利多卡因联合舒芬太尼和肾上腺素用于腹部子宫切除术:呼吸抑制与术后镇痛

Epidural lidocaine with sufentanil and epinephrine for abdominal hysterectomy under general anaesthesia: respiratory depression and postoperative analgesia.

作者信息

Dyer R A, Camden-Smith K, James M F

机构信息

Department of Anaesthesia, Groote Schuur Hospital, Observatory, South Africa.

出版信息

Can J Anaesth. 1992 Mar;39(3):220-5. doi: 10.1007/BF03008780.

Abstract

The purpose of this investigation was to compare the analgesic actions and side-effects of a 50 micrograms epidural bolus of sufentanil and 50 micrograms epinephrine, with a control group receiving saline and epinephrine. The method employed was a prospective, randomised, double-blind trial involving 40 ASA I or II patients for total abdominal hysterectomy. All received 1.5% lidocaine with 1/200,000 epinephrine epidurally before operation, until a block to T4 was established. Patients were anaesthetised, their tracheas were intubated, and they were allowed to breathe spontaneously before administration of the test drug. Results showed that sufentanil prolonged the duration of local anaesthesia (198 +/- 35 min vs 174 +/- 29 min; P less than 0.05), and of analgesia (288 +/- 85 min vs 188 +/- 42 min; P less than 0.01). There was an increase in somnolence in the sufentanil group (9/20 vs 2/20; P less than 0.05). Glycopyrollate was given to 11/20 patients in the sufentanil group vs 1/20 in the control group (P less than 0.01) following bradycardia and hypotension. Clinical respiratory depression occurred in the sufentanil group; 5/20 patients required controlled ventilation following apnoea greater than 20 sec. It is concluded that epidural sufentanil causes considerable cardiorespiratory depression in the setting of general anaesthesia, and should be used with caution in the spontaneously breathing, anaesthetised patient.

摘要

本研究的目的是比较50微克舒芬太尼硬膜外推注与50微克肾上腺素的镇痛作用及副作用,并与接受生理盐水和肾上腺素的对照组进行比较。采用的方法是一项前瞻性、随机、双盲试验,涉及40例ASA I或II级行全腹子宫切除术的患者。所有患者术前均接受1.5%利多卡因加1/200,000肾上腺素硬膜外阻滞,直至T4平面阻滞建立。患者麻醉后气管插管,在给予试验药物前允许自主呼吸。结果显示,舒芬太尼延长了局部麻醉时间(198±35分钟对174±29分钟;P<0.05)和镇痛时间(288±85分钟对188±42分钟;P<0.01)。舒芬太尼组嗜睡发生率增加(9/20对2/20;P<0.05)。舒芬太尼组11/20的患者在出现心动过缓和低血压后给予了格隆溴铵,而对照组为1/20(P<0.01)。舒芬太尼组出现临床呼吸抑制;5/20的患者在呼吸暂停超过20秒后需要控制通气。结论:在全身麻醉情况下,硬膜外舒芬太尼可引起相当程度的心肺抑制,在自主呼吸的麻醉患者中应谨慎使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验